otenaproxesul analgesic antiinflammatory drug developed antibe therapeutics nsaid structurally derived naproxen received approval commence phase ii clinical trials treatment osteoarthritis completing phase clinical trials drug completed trials gastrointestinal safety completed phase iib trials efficacy pain initial phase iii clinical trials failed meet necessary criteria advance next phase vivo studies demonstrated reduction zymosaninduced pain inflammation cytokineinduced bone preclinical studies also investigated treatment melanoma intestinal like nsaids otenaproxesul acts inhibitor cycloxygenase cox enzymes suppressing production prostaglandins additionally releases hydrogen sulfide gastrointestinal tract reducing gastrointestinal adverse effects drug article relating musculoskeletal system stub help wikipedia expanding httpsenwikipediaorgwikiotenaproxesul